Vitae Biomedical Co., Ltd. participated in the BioLink matchmaking event hosted by the Southern Taiwan Science Park, engaging with healthcare providers and distribution partners to explore practical pathways for clinical adoption and service deployment.

Through one-on-one discussions, the company initiated collaboration dialogues with major partners including Great Tree Pharmacy and Chi Mei Medical Center, focusing on future application scenarios and integration models.

With Great Tree Pharmacy, discussions explored opportunities to leverage existing cross-border retail and healthcare distribution networks, particularly in Southeast Asia. The collaboration aims to support localized service deployment and expand market reach through established channel infrastructure.

In parallel, discussions with Chi Mei Medical Center focused on integrating cancer screening services into home-based care workflows. The proposed model includes the incorporation of urine-based lung cancer detection and other non-invasive diagnostic solutions into patient and caregiver services, supporting early detection and improving overall care quality for high-risk populations.

These engagements highlight Vitae Biomedical’s ability to bridge clinical practice, distribution networks, and emerging preventive healthcare models. By connecting innovation with real-world healthcare delivery systems, the company continues to shorten the pathway from research to practical application.

Looking ahead, Vitae Biomedical will continue to strengthen strategic partnerships and expand both domestic and international deployment, advancing the adoption of non-invasive diagnostic solutions across clinical and care settings.